Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1965 1
1966 1
1968 1
1969 1
1972 3
1973 7
1974 4
1975 1
1976 4
1978 8
1979 9
1980 4
1981 6
1982 5
1983 10
1984 6
1985 3
1986 8
1987 15
1988 14
1989 8
1990 13
1991 11
1992 9
1993 12
1994 9
1995 14
1996 17
1997 28
1998 16
1999 30
2000 48
2001 52
2002 36
2003 49
2004 83
2005 83
2006 74
2007 111
2008 124
2009 128
2010 175
2011 201
2012 243
2013 231
2014 230
2015 269
2016 274
2017 276
2018 271
2019 313
2020 356
2021 397
2022 388
2023 336
2024 232

Text availability

Article attribute

Article type

Publication date

Search Results

4,702 results

Results by year

Filters applied: . Clear all
Page 1
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.
Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG. Shields RL, et al. Among authors: hong k. J Biol Chem. 2001 Mar 2;276(9):6591-604. doi: 10.1074/jbc.M009483200. Epub 2000 Nov 28. J Biol Chem. 2001. PMID: 11096108 Free article.
Mouse models for telomere and telomerase biology.
Cheong C, Hong KU, Lee HW. Cheong C, et al. Among authors: hong ku. Exp Mol Med. 2003 Jun 30;35(3):141-53. doi: 10.1038/emm.2003.20. Exp Mol Med. 2003. PMID: 12858012 Review.
Development of ligand-targeted liposomes for cancer therapy.
Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC. Noble CO, et al. Among authors: hong k. Expert Opin Ther Targets. 2004 Aug;8(4):335-53. doi: 10.1517/14728222.8.4.335. Expert Opin Ther Targets. 2004. PMID: 15268628 Review.
[Weaning].
Hong KP. Hong KP. Taehan Kanho. 1965;4(4):29-36. Taehan Kanho. 1965. PMID: 5213539 Korean. No abstract available.
Engineering therapeutic antibodies for improved function.
Presta LG, Shields RL, Namenuk AK, Hong K, Meng YG. Presta LG, et al. Among authors: hong k. Biochem Soc Trans. 2002 Aug;30(4):487-90. doi: 10.1042/bst0300487. Biochem Soc Trans. 2002. PMID: 12196120 Review.
Anti-HER2 immunoliposomes for targeted drug delivery.
Hong K, Kirpotin DB, Park JW, Shao Y, Shalaby R, Colbern G, Benz CC, Papahadjopoulos D. Hong K, et al. Ann N Y Acad Sci. 1999;886:293-6. doi: 10.1111/j.1749-6632.1999.tb09440.x. Ann N Y Acad Sci. 1999. PMID: 10667243 Review. No abstract available.
4,702 results